Advertisement
Screener

SANARA MEDTECH INC. (SMTI) Overview

SANARA MEDTECH INC. (SMTI) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.05; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.05; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -3.40; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.23; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$15.52$18.47$21.98$26.16$31.13$37.042025-11-062026-11-06$15.52$19.78$25.21$32.12$40.93$52.162021-11-082026-11-06$1.90$3.73$7.32$14.37$28.22$55.392016-11-072026-11-06$1.90$5.85$18.00$55.41$170.56$525.002006-11-062026-11-06$1.90$10.08$53.46$283.60$1,504.36$7,980.001994-04-072026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$31.63
Previous close
$35.09
Change
-$3.46
Change (%)
-9.86%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

SMTI
+50.28%
S&P 500
(m)

1 year

SMTI
+10.21%
S&P 500
(m)

3 years

SMTI
+12.72%
S&P 500
(m)

5 years

SMTI
+0.83%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.05

-3.48-2.55-1.63-0.700.2331 Mar 2025: estimate (m); actual -0.4131 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.2330 Jun 2025(m)30 Sept 2025: estimate (m); actual -3.4030 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.0531 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.0530 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.05(m)(m)
1 Jan 202631 Mar 2026(m)0.05(m)(m)
1 Jul 202530 Sept 2025(m)-3.40(m)(m)
1 Apr 202530 Jun 2025(m)-0.23(m)(m)
1 Jan 202531 Mar 2025(m)-0.41(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -4.36

-4.44-3.42-2.39-1.37-0.3431 Dec 2020: estimate (m); actual -0.7631 Dec 2020(m)31 Dec 2022: estimate (m); actual -1.0031 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.5231 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.1431 Dec 2024(m)31 Dec 2025: estimate (m); actual -4.3631 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-4.36(m)(m)
1 Jan 202431 Dec 2024(m)-1.14(m)(m)
1 Jan 202331 Dec 2023(m)-0.52(m)(m)
1 Jan 202231 Dec 2022(m)-1.00(m)(m)
1 Jan 202031 Dec 2020(m)-0.76(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 28.14M ■ Earnings -0.45M — Profit margin -1.61%

-42.88M-116.5%0.07M11.6%43.03M139.8%85.99M267.9%30 Sept 2025: revenue 26.33M; earnings -30.41M; profit margin -115.48%30 Sept 202531 Dec 2025: revenue 27.55M*; earnings 73.52M*; profit margin 266.88%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 27.80M; earnings 0.46M; profit margin 1.65%31 Mar 202630 Jun 2026: revenue 28.14M; earnings -0.45M; profit margin -1.61%30 Jun 2026

31 Dec 2025 ■ Revenue 103.12M ■ Earnings 37.56M — Profit margin 36.43%

-21.26M-18.3%24.64M0.3%70.54M18.8%116.44M37.4%31 Dec 2022: revenue 45.84M; earnings -7.94M; profit margin -17.31%31 Dec 202231 Dec 2023: revenue 64.99M; earnings 4.30M; profit margin 6.62%31 Dec 202331 Dec 2024: revenue 86.67M; earnings 9.66M; profit margin 11.15%31 Dec 202431 Dec 2025: revenue 103.12M; earnings 37.56M; profit margin 36.43%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$31.63(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$31.63High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning SMTI

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$43.11M
Profit margin
39.26%
Return on assets · 12 month
51.35%
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
205.49K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-0.54%*
Total return · month
1.50%*
Total return · quarter
42.76%*
Total return · half year
106.90%*
Total return · year to date
50.28%*
Total return · 1 year
10.21%*
Total return · 3 years
12.72%*
Total return · 5 years
0.83%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$109.81M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

SANARA MEDTECH INC. Overview

View more →

(m)

(m)

SEC CIK
714256
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
1200 SUMMIT AVE, SUITE 414, FORT WORTH, Texas, 76102, United States
Fiscal year end
1231
Phone
817-529-2300

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Lifeward Ltd. (LFWD)$0.021B